The cost-effectiveness of icosapent ethyl in combination with statin therapy compared with statin alone for cardiovascular risk reduction
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The cost-effectiveness of icosapent ethyl in combination with statin therapy compared with statin alone for cardiovascular risk reduction
Authors
Keywords
-
Journal
European Journal of Preventive Cardiology
Volume -, Issue -, Pages 204748731989664
Publisher
SAGE Publications
Online
2020-01-11
DOI
10.1177/2047487319896648
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The cost-effectiveness of canakinumab for secondary prevention of cardiovascular disease: The Australian healthcare perspective
- (2019) Ella Zomer et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The cost-effectiveness of omega-3 polyunsaturated fatty acids – The Australian healthcare perspective
- (2019) Lan Gao et al. European Journal of Internal Medicine
- Cost-Effectiveness of Statin Plus Eicosapentaenoic Acid Combination Therapy for Cardiovascular Disease Prevention in Japanese Patients With Hypercholesterolemia ― An Analysis Based on the Japan Eicosapentaenoic Acid Lipid Intervention Study (JELIS) ―
- (2018) Satoshi Kodera et al. CIRCULATION JOURNAL
- Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study
- (2018) Brett Doble et al. Health and Quality of Life Outcomes
- FISHing for the Miracle of Eicosapentaenoic Acid
- (2018) John J.P. Kastelein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Utility and quality-adjusted life-years in coronary artery disease
- (2017) Sara Michelly Gonçalves Brandão et al. MEDICINE
- Management of residual risk after statin therapy
- (2016) Christina Reith et al. ATHEROSCLEROSIS
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- Health-related quality of life measured using the EQ-5D–5L: South Australian population norms
- (2016) Nikki McCaffrey et al. Health and Quality of Life Outcomes
- Comprehensive Profiling of Plasma Fatty Acid Concentrations in Young Healthy Canadian Adults
- (2015) Salma A. Abdelmagid et al. PLoS One
- Impact of Cardiovascular Events on Change in Quality of Life and Utilities in Patients After Myocardial Infarction
- (2014) Eldrin F. Lewis et al. JACC-Heart Failure
- ANCHOR Trial Conclusions Regarding the Effects of Pure Eicosapentaenoic Acid on Low-Density Lipoprotein Cholesterol
- (2013) Seth J. Baum AMERICAN JOURNAL OF CARDIOLOGY
- Marine n-3 fatty acids in adipose tissue and development of atrial fibrillation: a Danish cohort study
- (2013) Thomas Andersen Rix et al. HEART
- Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
- (2012) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study
- (2012) Linda J Cobiac et al. BMC PUBLIC HEALTH
- High concentrations of omega-3 fatty acids are associated with the development of atrial fibrillation in the Japanese population
- (2012) Takeshi Tomita et al. HEART AND VESSELS
- Fish Oil and Postoperative Atrial Fibrillation
- (2012) Dariush Mozaffarian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Estimating Health and Economic Benefits from Using Prescription Omega-3 Fatty Acids in Patients With Severe Hypertriglyceridemia
- (2011) Stuart Samuel et al. AMERICAN JOURNAL OF CARDIOLOGY
- The costs of atrial fibrillation in patients with cardiovascular comorbidities--a longitudinal analysis of German health insurance data
- (2011) T. Reinhold et al. EUROPACE
- Relationships between Plasma Fatty Acid Composition and Coronary Artery Disease
- (2011) Hiroshige Itakura et al. Journal of Atherosclerosis and Thrombosis
- Population Trends of Recurrent Coronary Heart Disease Event Rates Remain High
- (2010) Tom G. Briffa et al.
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started